June 15, 2022
Health IT
  • TheDigital Medicine Society (DiMe) – a digital health collaborative that includes Google, the Food and Drug Administration (FDA), and the Harvard-MIT Center for Regulatory Science – announced plans to launch an interactive, open-access regulatory support tool for health care tech companies. The Digital Medicine Society’s Digital Health Regulatory Pathways will consolidate guidance from government agencies for increasingly popular — but often unregulated — health care options to help developers determine whether their products should be regulated. The tool will be publicly available early next year. (Press release here)